Healthcare Wrap: Xenitra Soars on China Drug Deal as Artrya Slides

• Xenitra (ASX:XEN) jumped 60.00% after securing a three-year procurement agreement worth at least A$12 million with Kangsheng.
• Artrya (ASX:AYA) fell 28.55% despite two US health systems already generating revenue from its Salix platform.
• InteliCare (ASX:ICR) rose 27.78% after reporting its first positive cash-flow quarter since listing.
• 4DMedical (ASX:4DX) gained 16.72% after signing SimonMed Imaging to deploy its lung imaging system across more than 170 US centres.